The Lustgarten Foundation is the largest private funder of pancreatic cancer research in the world.
To date, we’ve invested over $282M in high-risk, high-reward research to accelerate and expand life-saving treatment options. We lead a unique, collaborative, science-focused strategy and have been a driving force in every major advancement in pancreatic cancer research since 1998.
Progress is paramount. We drive bold, innovative research with the singular mission: transforming pancreatic cancer into a curable disease.
Lustgarten Announcements
With survival rates hovering around 13 percent five years after diagnosis, the need for innovative and effective pancreatic cancer treatment remains critical. The good news is the recent meeting of […]
November is Pancreatic Cancer Awareness Month, a month dedicated to spreading awareness and education about pancreatic cancer. This year, as the global leader in advancing treatment and cures, we encourage […]
Welcome to Lustgarten LIVE; our live-streamed webinar series created to introduce you to best-in-class experts from the field of pancreatic cancer research, technology, and science. Here, you will find registration […]
SUSAN’s story
From Nurse to Patient
When Susan was diagnosed with pancreatic cancer, cutting-edge drugs and a supportive medical team helped her go from patient to survivor. Now she raises funds for continued research through a Lustgarten Foundation Walk for Research.
Read Susan’s Story
News from Our Partners
Northwell Health Cancer Institute
NY Pancreatic Cancer Consortium
Lustgarten is a proud sponsor of Northwell Health Cancer Institute’s Inaugural NY Pancreatic Cancer Consortium. We applaud the work led by keynote speaker, Andrew M. Aguirre, MD, PhD
The morbidity and mortality of cancer is still a public health crisis. Pancreatic cancer, in particular, has one of the worst survival rates. Increased knowledge of new treatment methodologies, new research being done in the disease and how to best care for the patient with Pancreas cancer are vitally important to improving the survival rate of patients with pancreatic cancer.
This conference, planned by and for MDs, and PAs, will provide the opportunity for participants to increase their knowledge and competencies in the care and management of pancreatic cancer. All members of the healthcare team who are interested in the field of Pancreatic Cancer, NPs, RNs, Residents, Fellows, Medical Students, and Northwell Retirees are invited to attend.
Let’s Win Pancreatic Cancer
AACR Special Conference Highlights Advances in Pancreatic Cancer Research
With survival rates hovering around 13 percent five years after diagnosis, the need for innovative and effective pancreatic cancer treatment remains critical. The good news is the recent meeting of the AACR showed a dedicated global effort is underway not only to better understand pancreatic cancer but also to find ways to better treat this disease.
Pancreatic Cancer Research Updates from ASCO 2024
The American Society of Clinical Oncology (ASCO) Annual Meeting brought together physician-scientists and researchers from across the world to showcase potentially promising treatment breakthroughs for many different types of cancer.
» Learn more about pancreatic cancer research updates from ASCO 2024 «
Genetic Testing Changed My Chemo Protocol
In Spring 2015, Greg Jacobson started having pain in his upper left abdomen a constant nausea. After a series of blood tests, a CT scan, a PET scan, an endoscopy and a colonoscopy, Greg was diagnosed with stage III pancreatic and duodenal cancer. Getting the right chemo protocol was a gamechanger in Greg’s treatment.
In Safe Hands: Selecting the Right Whipple Surgeon
When it comes to picking the right surgeon for a complex surgery like the Whipple procedure (also known as pancreaticoduodenectomy), it quite literally can be a life-or-death choice. So where do you even begin?
» Read more to find out how to pick the best surgeon for you «
